title: Human immunodeficiency virus type 1 Gag assembly through assembly intermediates.
abstract: Human immunodeficiency virus Gag protein self-assembles into spherical particles, and recent reports suggest the formation of assembly intermediates during the process. To understand the nature of such assembly intermediates along with the mechanism of Gag assembly, we employed expression in Escherichia coli and an in vitro assembly reaction. When E. coli expression was performed at 37 degrees C, Gag predominantly assembled to a high order of multimer, apparently equivalent to the virus-like particles obtained following Gag expression in eukaryotic cells, through the formation of low orders of multimer characterized with a discreet sedimentation value of 60 S. Electron microscopy confirmed the presence of spherical particles in the E. coli cells. In contrast, expression at 30 degrees C resulted in the production of only the 60 S form of Gag multimer, and crescent-shaped structures or small patches with double electron-dense layers were accumulated, but no complete particles. In vitro assembly reactions using purified Gag protein, when performed at 37 degrees C, also produced the high order of Gag multimers with some 60 S multimers, whereas the 30 degrees C reaction produced only the 60 S multimers. However, when the 60 S multimers were cross-linked so as not to allow conformational changes, in vitro assembly reactions at 37 degrees C did not produce any higher order of multimers. ATP depletion did not halt Gag assembly in the E. coli cells, and the addition of GroEL-GroES to in vitro reactions did not facilitate Gag assembly, indicating that conformational changes rather than protein refolding by chaperonins, induced at 37 degrees C, were solely responsible for the Gag assembly observed here. We suggest that Gag assembles to a capsid through the formation of the 60 S multimer, possibly a key intermediate of the assembly process, accompanied with conformational changes in Gag.
authors.affiliation: Kitasato Institute of Life Sciences, Kitasato University, Shirokane 5-9-1, Minato-ku, Tokyo 108-8641, Japan. morikawa@lisci.kitasato-u.ac.jp
authors.forename: Yuko
authors.initials: Y
authors.lastname: Morikawa
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Goto
authors.forename: Fumitaka
authors.initials: F
authors.lastname: Momose
mesh_terms: D002213:Capsid / Q000378:metabolism / Q000648:ultrastructure; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism / Q000648:ultrastructure; D015683:Gene Products, gag / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics; D015750:Genes, gag; D015497:HIV-1 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D066298:In Vitro Techniques; D046911:Macromolecular Substances; D008854:Microscopy, Electron; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics; D019065:Virus Assembly
chemical_list: D015683:Gene Products, gag; D046911:Macromolecular Substances; D011994:Recombinant Proteins